GlassScriptPhysician profile
Diane Solic
NPI 1548708605
$1,172.84
in general payments reported to CMS, 2019-2025
25 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.51 · 2022: $276 · 2023: $196 · 2024: $291 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $877.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $168.21 | 2025 | Breztri, Airsupra |
| Lilly USA, LLC | $153.59 | 2022-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $144.45 | 2022-2025 | |
| Novo Nordisk INC | $115.47 | 2022-2025 | Ozempic, Rybelsus |
| Exact Sciences Corporation | $110.69 | 2023-2025 | Cologuard Collection Kit |
| Irhythm Technologies, INC. | $61.23 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Pfizer INC. | $54.09 | 2023-2025 | |
| Depuy Synthes Sales INC. | $35.96 | 2024 | Orthovisc |
| Si-Bone, INC. | $34.96 | 2022 | |
| Tms Neurohealth Centers INC. | $29.16 | 2025 | Tms Neurohealth Centers INC. |
| Astellas Pharma US INC | $23.11 | 2024 | Veozah |
| Organon LLC | $22.04 | 2022 | |
| Hologic Sales and Service, LLC | $21.73 | 2025 | Aptima |
| Philips North America LLC | $19.70 | 2024 | (Ck7) Extended Holter |
| Ethicon US, LLC | $19.51 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $19.49 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Inspire Medical Systems, INC. | $17.97 | 2024 | Inspire |
| Nevro Corp. | $16.72 | 2022 | |
| Viiv Healthcare Company | $16.40 | 2024 | Apretude |
| Glaxosmithkline, LLC. | $16.39 | 2022 | |
| Sanofi-Aventis U.S. LLC | $15.60 | 2022 | |
| Phadia US INC. | $15.05 | 2025 | Immunocap |
| Boston Scientific Corporation | $14.31 | 2025 | General - Pain Management |
| Sonex Health, INC. | $13.74 | 2025 | Sx-One Microknife |
| Idorsia Pharmaceuticals US INC | $13.27 | 2024 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Solic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.